← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Icahn School Of Medicine At Mount Sinai
New York, NY
$6,651,734,468
Total funding
4,515
Grants
Funding over time
peak $590.5M · FY2005–25$1B$750M$500M$250M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,240,552,652 · 4241
CDC$269,593,558 · 65
DOD$126,495,267 · 143
AHRQ$20,398,882 · 15
NSF$16,048,675 · 48
NASA$6,497,608 · 5
ATSDR$4,825,000 · 1
FDA$4,105,867 · 4
HHS (Other)$677,278 · 1
SAMHSA$0 · 1
By mechanism
R01$2,837,325,080 · 1347
U01$641,355,980 · 132
N01$408,928,014 · 20
P01$316,180,620 · 263
U19$228,348,458 · 135
U10$171,183,935 · 15
Investigators at Icahn School Of Medicine At Mount Sinai
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
WTC Responder Health Consortium Clinical Center$30,810,332
U10 · FY2009 · OH
WTC Responder Health Consortium Clinical Center$30,608,606
U10 · FY2010 · OH
WTC Responder Health Consortium Clinical Center$29,943,669
U10 · FY2008 · OH
AIDS Malignancy Consortium (AMC)$22,174,221
UM1 · FY2021 · CA
AIDS Malignancy Consortium (AMC)$22,098,764
UM1 · FY2022 · CA
AIDS Malignancy Consortium (AMC)$22,055,360
UM1 · FY2023 · CA
AIDS Malignancy Consortium (AMC)$21,331,737
UM1 · FY2024 · CA
Modeling Immunity for Biodefense: Influenza virus$17,219,600
N01 · FY2010 · AI
TAS::75 0872::TAS TRANSLATIONAL NANOMEDICALTHERAPIES FOR CARDIAC & VASCULAR DIS$16,447,515
N01 · FY2010 · HL
Consortium for Advancing Management and Prevention of Cancer in People with HIV$16,392,131
UM1 · FY2025 · CA
WTC Responder Health Consortium Clinical Center$15,913,261
U10 · FY2007 · OH
DEVELOPMENT OF A VACCINE CANDIDATE FOR CORONAVIRUSES$15,898,493
N01 · FY2023 · AI
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component A: Vaccine Center$15,829,335
N01 · FY2024 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA RESEARCH$13,997,120
N01 · FY2023 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA RESEARCH$13,681,100
N01 · FY2021 · AI
High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials$13,559,983
U24 · FY2017 · CA
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA VACCINE RESEARCH$12,837,354
N01 · FY2025 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM$11,979,672
N01 · FY2020 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA RESEARCH$11,756,332
N01 · FY2022 · AI
Mount Sinai CHEAR Network Laboratory Hub$10,400,000
U2C · FY2015 · ES